Tag: biosimilars vs generics
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Categories
Medications
Archives
Recent-posts
Compare Prednisolone with Alternatives: What Works Best for Inflammation and Autoimmune Conditions
Oct, 29 2025
Antibiotic Resistance: Understanding Why Your Medication Changes and New Treatment Choices
Apr, 26 2025
Crossover Trial Design: How Bioequivalence Studies Are Structured
Dec, 15 2025
Candidemia & Disseminated Candida Infections: Why Patient Education Matters
Oct, 21 2025
Buy Generic Claritin (Loratadine) Online Cheap: Safe 2025 Prices, Deals, and Buyer’s Guide
Sep, 9 2025